MARINELLI ANDREOLI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 170
EU - Europa 133
AS - Asia 52
SA - Sud America 1
Totale 356
Nazione #
US - Stati Uniti d'America 169
IT - Italia 53
IE - Irlanda 39
CN - Cina 19
UA - Ucraina 17
HK - Hong Kong 16
SG - Singapore 14
RU - Federazione Russa 8
FI - Finlandia 4
DE - Germania 3
CH - Svizzera 2
GB - Regno Unito 2
IN - India 2
SE - Svezia 2
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
KR - Corea 1
MX - Messico 1
Totale 356
Città #
Chandler 46
Dublin 39
Perugia 23
San Mateo 18
Hong Kong 16
Altamura 13
Singapore 11
Boardman 9
Medford 9
Princeton 9
Jacksonville 8
Lawrence 8
Beijing 7
Rome 7
Ashburn 6
Wilmington 6
Des Moines 3
Redmond 3
Amelia 2
Andover 2
Corridonia 2
Hyderabad 2
Los Angeles 2
Redwood City 2
Ann Arbor 1
Belo Horizonte 1
Cepagatti 1
Hanover 1
Helsinki 1
Napoli 1
Norwalk 1
Olomouc 1
Saint Petersburg 1
San Paolo di Civitate 1
Seoul 1
Terni 1
Totale 265
Nome #
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 51
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 49
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 49
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 42
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 42
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 41
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 39
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 38
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 29
Totale 380
Categoria #
all - tutte 2.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 2 0 2 5 2 2 2 6 1 0
2020/202147 0 2 0 2 26 1 5 0 6 0 2 3
2021/202267 0 11 0 0 1 1 0 19 1 11 14 9
2022/2023139 9 27 6 5 10 18 0 9 49 0 4 2
2023/202466 7 3 3 2 0 5 10 0 6 4 19 7
2024/202512 0 9 3 0 0 0 0 0 0 0 0 0
Totale 380